skip navigation nih record
Vol. LX, No. 7
April 4, 2008

previous story

next story

Symposium To Show What We’ve Learned About Mood Disorders

With almost 21 million adults in the United States suffering from mood disorders each year, the indirect effects reach far beyond the individual sufferer—to spouses, children, other family members and friends, as well as to the workplace, schools, health care systems and local and global economies.

In a symposium on Friday, Apr. 18 from noon to 3:30 p.m. in Masur Auditorium, Bldg. 10, a panel of five National Institute of Mental Health researchers will discuss mood disorders. Topics include what scientific investments are yielding in efforts to understand the causes of these often disabling conditions; new medical and non-pharmaceutical approaches to addressing symptoms and prevention; how to distinguish normal behavioral fluctuations in children and teens from symptoms of depression or bipolar disorder; and how to identify signs of suicide risk and best ways to intervene.  

Speakers and topics include:

“The Global Effects of Mood Disorders–An Overview,” by Dr. Husseini Manji, director, Mood & Anxiety Disorders Program.

“Help in the Now, Help in the Wings: Medical, Non-pharmacologic and Complementary Treatments,” by Dr. Carlos Zarate, chief, Experimental Therapeutics, Mood & Anxiety Disorders Program.

“No Ordinary Childhood: Mood Disorders in Our Way,” by Dr. Ellen Leibenluft, chief, section on bipolar spectrum disorders, Mood & Anxiety Disorders Program.

“Fatal Despair and the Reason to Care,” by Dr. Jane Pearson, chair, NIMH suicide research consortium, Division of Services and Intervention Research.

“Getting Better, Staying Well: The People Involved,” by Dr. David I. Sommers, scientific review officer, Division of Extramural Activities.

The event—also broadcast live at http://videocast.—is aimed at updating NIH staff on research and clinical issues related to mood disorders. Guests, volunteers and patients are also welcome, with seating on a first-come, first-served basis.

Sign language interpreters will be available. For more information or to request other reasonable accommodation, contact Sophia Glezos Voit at or phone (301) 443-4533. NIHRecord Icon

back to top of page